This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 03/04/2019
Location: Silver Spring, MD
Subject: The United Kingdom Government Chief Scientific Advisor: Clinical Trial Guidelines
FDA Participant/Group: CARLYLE MCWILLIAMS;
Non FDA Participant/Group: Patrick Vallance (The United Kingdom Government);

Event Date: 03/05/2019
Location: Washington, DC
Subject: National Association of Attorneys General (NAAG): Tobacco Control, Prevention, Control of Infectious Diseases, and Promoting Immunizations
FDA Participant/Group: CARLYLE MCWILLIAMS; MITCHELL ZELLER; LAUREN ROTH; NICHOLAS ALEXANDER;
Non FDA Participant/Group: Several members from the National Association of Attorneys General

Event Date: 03/06/2019
Location: Washington, DC
Subject: Overcoming Obstacles: Patient Access to Innovation
FDA Participant/Group: KATHLEEN QUINN;
Non FDA Participant/Group: Government, media, industry, and other registered guests

Event Date: 03/06/2019
Location: Silver Spring, MD
Subject: Warning Letter on Compliance with Drug Supply Chain Security Act
FDA Participant/Group: LAUREN SILVIS;
Non FDA Participant/Group: Brian Tyler, Lori Schechter (McKesson Corporation);

Event Date: 03/07/2019
Location: New York, NY
Subject: The Alexandria Summit: Innovate AG 2019: Nutrition and Food Safety Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Event Date: 03/08/2019
Location: Weston, CT
Subject: Vaping 101: Facts about E-cigarettes
FDA Participant/Group: N/A
Non FDA Participant/Group: Several students, parents, and staff from the Weston Middle School

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy & Response

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/05/2019
Location: Bethesda, MD
Subject: International Society for Cellular Therapy: FDA Cell Therapy Liaison Meeting
FDA Participant/Group: DAVID CHO; WILSON BRYAN; RACHAEL ANATOL;
Non FDA Participant/Group: N/A

Event Date: 03/07/2019
Location: Washington, DC
Subject: Association for Clinical and Translational Science Meeting: FDA's Approach to the Development and Regulation of Gene Therapy Products
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 03/07/2019
Location: Silver Spring, MD
Subject: 22nd United States–Japan Cellular and Gene Therapy Conference: Adeno–Associated Virus–Medicated Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 03/07/2019
Location: Orlando, FL
Subject: Research and Education: Consumer Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the (food safety educators industry); Hilary Thesmar (Food Marketing Institute); Carmen Rottenberg (United States Department of Agriculture); Rob Tauxe (Centers for Disease Control and Prevention);

Event Date: 03/08/2019
Location: College Park, MD
Subject: Consumer and Public Health Nutrition Coalition Quarterly Meeting
FDA Participant/Group: DOUGLAS BALENTINE; ROBIN MCKINNON; JENNIFER DOOREN; KARI BARRETT; CONRAD CHOINIERE; MAYA MAROTO; CLAUDINE KAVANAUGH; DAVID GOLDMAN; JANESIA ROBBS;
Non FDA Participant/Group: Susan Bishop (American Heart Association, Inc.); Charlotte Vallaeys (Consumer Reports, Inc.); Larry McNeely (American Diabetes Association); Pepin Tuma (Academy of Nutrition and Dietetics); Colin Schwartz, Laura MacCleery (Center for Science in the Public Interest); Gaby Witte (American Public Health Association); Mollie Van Lieu (United Fresh); Daphne Delgado (Trust for America's Health); Madeline Curtis (American Academy of Pediatrics);

Event Date: 03/08/2019
Location: College Park, MD
Subject: Nutrition Innovation Messaging Strategy
FDA Participant/Group: N/A
Non FDA Participant/Group: John Courtney, Sarah Ohlhorst (American Society for Nutrition);

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

Event Date: 03/07/2019
Location: College Park, Maryland
Subject: FDA’s Active Role in the Evaluation of Talc Safety
FDA Participant/Group: CAROLYN JASPERSE; DEBORAH SMEGAL; NAKISSA SADRIEH; ELIZABETH DICKINSON; LINDA KATZ; STEVEN MUSSER; ALEXANDRA JABS;
Non FDA Participant/Group: John Ewald, Mary Kathleen O'Connor, Shaila Rahman Diwan (Orrick Herrington & Sutcliffe, LLP); Julie Peng, Sheldon Bradshaw (King & Spalding, LLP ); Matthew Sanchez (RJ Lee Group); Several members from (Johnson & Johson Services, Inc.); Lisa Dwyer (King & Spalding, LLP);